Engystol Oral Vials

 

Indications:
To activate the non-specific defensive mechanism, particularly in the case of influenza and questionable virus diseases.

For the lowering of high homotoxin levels, regulation of enzyme functions, and stimulation of the major defensive and lymphatic systems in neuralgic and other disorders including influenza, cold sores, and feverish conditions.

Composition:

Tablets:
Each 300 mg tablet contains:

Asclepias vincetoxicum 6X, 10X, 30X
(feverish viral diseases including influenza and mumps)
75 mg each;

Sulphur 4X, 10X
(flashes of heat throughout body; lips dry, bright red, burning)
37.5 mg each
in a lactose base.

Oral vials:
Each 100 ml contains:

Asclepias vincetoxicum 6X, 10X, 30X
0.6 ml each;

Sulphur 4X, 10X
0.3 ml each
in an isotonic sodium chloride solution base.

Side effects:
None known.

Interactions with other medication:
None known.

Dosage:

Tablets:
Adults and children above 6 years:
1 tablet sublingually or dissolved completely in mouth 3 times daily or as directed by a physician.

Infants and children to 6 years:
1/2 the adult dosage.

Oral vials:
Adults and children above 6 years:
In general, 1 vial 1-3 times daily.

Children to 6 years:
1/2 the adult dosage.

Unused portion of open vials should be discarded.
Not for injection.

Dosage forms:

Tablets: Bottle containing 100 tablets.
Oral vials: Pack containing 10 vials of 1.1 ml.

Pharmacological and clinical notes
Constituents Indications

Vincetoxicum (swallowwort)
Stimulation of the body's own defenses with vascular and sympathetic action, e.g. in feverish viral diseases such as influenza, mumps, etc.

Sulfur (sulphur)
Reagent in all diseases; cellular activity is influenced catalytically.

Based on the individual homeopathic constituents of Engystol, therapeutic possibilities result for the activation of the body's own non-specific defenses, particularly in vague feverish infections and for influenza, as well as after Roentgen irradiation and generally in viral infections of all kinds, viral influenza, viral pneumonia and viral hepatitis, as well as after vaccination (against smallpox), also stomatitis aphthosa.
Many skin diseases (neurodermatitis, urticaria, pruritus simplex et vulvae, eczema, furunculosis, etc.)

Diseases of the respiratory organs (bronchitis, bronchiectasis, pertussis, pneumonia and asthma), of the heart and circulation (paroxysmal tachycardia, endocarditis) Migraine, neuralgia, causalgia.

Allergies of every kind and location (including hay fever) and various forms of rheumatism (including gout), of the kidneys, liver and central nervous system.

Experimentally in toxoplasmosis (together with Traumeel i.v.) Impregnation and degeneration phases in the form of therapeutical damage (in addition to the intermediary acids of the citric acid cycle)

Engystol exerts a generally lowering action on high homotoxin levels, especially after therapeutical damage with the presence of impregnation and possibly also degeneration phases, particularly also in virus diseases, which are characterised by the penetration of the virus (homotoxin) into the cell.

Here Engystol has no direct virostatic or virocidal effect.

The effect of Fngystol rests, rather, on the vincetoxin which acts similarly to aconitine, and on the asclepiadic acid (constituent of Vincetoxicum officinale), with action on the vessels and sympathetic nervous system, as well as depending on colloidal sulphur, through which, by unblocking disturbed enzyme functions (sulphide enzymes), a general non-specific stimulation of the major defensive system takes place and the way is cleared for a far-reaching detoxication.

Engystol, consequently, exercises (in a similar way to Lymphomyosot), also a channelling action on the whole mesenchyma, and particularly on the Iymphatic system. This forms the foundation also for the indications of Engystol for allergies, secondary diseases and sequelae (such as agranulocytosis, neuritis, impairment of the liver, kidneys, bone marrow and myocardium; nephritis, etc.)

In serious feverish reaction phases, e.g. sepsis, after Engystol occasionally, at first, there is a slight worsening lasting from 3-5 hours, followed by a compensatory curative phase.

The dosage is adjusted according to the disease, the clinical picture and the stage of the illness:

1 ampule i.v., i.m., s.c.
1-3 times weekly, possibly together with
the patient's own blood.

For viral diseases 1 ampule i.v. daily; for small children and infants i.m. or s.c. until an improvement is observed.

For influenza, mixed injections
(1 ampule i.m., possibly with the patient's own blood)
together with Gripp-Heel (possibly 2 ampules) and Traumeel.

Site Navigation and Quick Links

Home • Health Club • Site Index • Library • Physicians Only • Checkout
Vitamins • Herbs • Minerals • Amino Acids • Enzymes • Hormones
Homeopathics • Ayurveda • Glandulars • Fatty Acids • Xtra-Cell

Alphabetical Product Index • Health Function Index
Condition Specific Formulas • The Latest Health Research